These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 30485484)

  • 41. Novel para-phenyl substituted diindolylmethanes protect against MPTP neurotoxicity and suppress glial activation in a mouse model of Parkinson's disease.
    De Miranda BR; Popichak KA; Hammond SL; Miller JA; Safe S; Tjalkens RB
    Toxicol Sci; 2015 Feb; 143(2):360-73. PubMed ID: 25406165
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Loss of collapsin response mediator protein 4 suppresses dopaminergic neuron death in an 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced mouse model of Parkinson's disease.
    Tonouchi A; Nagai J; Togashi K; Goshima Y; Ohshima T
    J Neurochem; 2016 Jun; 137(5):795-805. PubMed ID: 26991935
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Alteration of nuclear factor-kappaB pathway promote neuroinflammation depending on the functions of estrogen receptors in substantia nigra after 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine treatment.
    Mitra S; Ghosh N; Sinha P; Chakrabarti N; Bhattacharyya A
    Neurosci Lett; 2016 Mar; 616():86-92. PubMed ID: 26827723
    [TBL] [Abstract][Full Text] [Related]  

  • 44. PPAR-α agonist fenofibrate protects against the damaging effects of MPTP in a rat model of Parkinson's disease.
    Barbiero JK; Santiago R; Tonin FS; Boschen S; da Silva LM; Werner MF; da Cunha C; Lima MM; Vital MA
    Prog Neuropsychopharmacol Biol Psychiatry; 2014 Aug; 53():35-44. PubMed ID: 24593945
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Pre-clinical Studies Identifying Molecular Pathways of Neuroinflammation in Parkinson's Disease: A Systematic Review.
    Fathi M; Vakili K; Yaghoobpoor S; Qadirifard MS; Kosari M; Naghsh N; Asgari Taei A; Klegeris A; Dehghani M; Bahrami A; Taheri H; Mohamadkhani A; Hajibeygi R; Rezaei Tavirani M; Sayehmiri F
    Front Aging Neurosci; 2022; 14():855776. PubMed ID: 35912090
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Anti-neuroinflammatory effects of DPTP, a novel synthetic clovamide derivative in in vitro and in vivo model of neuroinflammation.
    Lim HW; Park JI; More SV; Park JY; Kim BW; Jeon SB; Yun YS; Park EJ; Yoon SH; Choi DK
    Brain Res Bull; 2015 Mar; 112():25-34. PubMed ID: 25596423
    [TBL] [Abstract][Full Text] [Related]  

  • 47. NF-κB/c-Rel DNA-binding is reduced in substantia nigra and peripheral blood mononuclear cells of Parkinson's disease patients.
    Porrini V; Pilotto A; Vezzoli M; Lanzillotta A; Gennari MM; Bonacina S; Alberici A; Turrone R; Bellucci A; Antonini A; Padovani A; Pizzi M
    Neurobiol Dis; 2023 May; 180():106067. PubMed ID: 36893901
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Src Inhibition Attenuates Neuroinflammation and Protects Dopaminergic Neurons in Parkinson's Disease Models.
    Yang H; Wang L; Zang C; Wang Y; Shang J; Zhang Z; Liu H; Bao X; Wang X; Zhang D
    Front Neurosci; 2020; 14():45. PubMed ID: 32132891
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Astragaloside IV ameliorates motor deficits and dopaminergic neuron degeneration via inhibiting neuroinflammation and oxidative stress in a Parkinson's disease mouse model.
    Yang C; Mo Y; Xu E; Wen H; Wei R; Li S; Zheng J; Li W; Le B; Chen Y; Pan H; Huang S; Wang S; Wang Q
    Int Immunopharmacol; 2019 Oct; 75():105651. PubMed ID: 31401385
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Nuclear Factor Kappa B: A Nobel Therapeutic Target of Flavonoids Against Parkinson's Disease.
    Singh NK; Singh A; Mayank
    Comb Chem High Throughput Screen; 2024 Jan; ():. PubMed ID: 38243959
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Attenuation of neuroinflammatory responses and behavioral deficits by Ligusticum officinale (Makino) Kitag in stimulated microglia and MPTP-induced mouse model of Parkinson's disease.
    Kim BW; Koppula S; Park SY; Kim YS; Park PJ; Lim JH; Kim IS; Choi DK
    J Ethnopharmacol; 2015 Apr; 164():388-97. PubMed ID: 25449453
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Phytic acid attenuates inflammatory responses and the levels of NF-κB and p-ERK in MPTP-induced Parkinson's disease model of mice.
    Lv Y; Zhang Z; Hou L; Zhang L; Zhang J; Wang Y; Liu C; Xu P; Liu L; Gai X; Lu T
    Neurosci Lett; 2015 Jun; 597():132-6. PubMed ID: 25929185
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Inhibition of cathepsin L alleviates the microglia-mediated neuroinflammatory responses through caspase-8 and NF-κB pathways.
    Xu S; Zhang H; Yang X; Qian Y; Xiao Q
    Neurobiol Aging; 2018 Feb; 62():159-167. PubMed ID: 29154036
    [TBL] [Abstract][Full Text] [Related]  

  • 54. RAGE Silencing Ameliorates Neuroinflammation by Inhibition of p38-NF-κB Signaling Pathway in Mouse Model of Parkinson's Disease.
    Wang X; Sun X; Niu M; Zhang X; Wang J; Zhou C; Xie A
    Front Neurosci; 2020; 14():353. PubMed ID: 32410941
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Eupatilin prevents behavioral deficits and dopaminergic neuron degeneration in a Parkinson's disease mouse model.
    Zhang Y; Qin L; Xie J; Li J; Wang C
    Life Sci; 2020 Jul; 253():117745. PubMed ID: 32376269
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Vitamin D Treatment Attenuates Neuroinflammation and Dopaminergic Neurodegeneration in an Animal Model of Parkinson's Disease, Shifting M1 to M2 Microglia Responses.
    Calvello R; Cianciulli A; Nicolardi G; De Nuccio F; Giannotti L; Salvatore R; Porro C; Trotta T; Panaro MA; Lofrumento DD
    J Neuroimmune Pharmacol; 2017 Jun; 12(2):327-339. PubMed ID: 27987058
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Naringenin Produces Neuroprotection Against LPS-Induced Dopamine Neurotoxicity via the Inhibition of Microglial NLRP3 Inflammasome Activation.
    Chen C; Wei YZ; He XM; Li DD; Wang GQ; Li JJ; Zhang F
    Front Immunol; 2019; 10():936. PubMed ID: 31118933
    [No Abstract]   [Full Text] [Related]  

  • 58. Icariin Reduces Dopaminergic Neuronal Loss and Microglia-Mediated Inflammation
    Wang GQ; Li DD; Huang C; Lu DS; Zhang C; Zhou SY; Liu J; Zhang F
    Front Mol Neurosci; 2017; 10():441. PubMed ID: 29375304
    [TBL] [Abstract][Full Text] [Related]  

  • 59. NADPH ameliorates MPTP-induced dopaminergic neurodegeneration through inhibiting p38MAPK activation.
    Zhou JS; Zhu Z; Wu F; Zhou Y; Sheng R; Wu JC; Qin ZH
    Acta Pharmacol Sin; 2019 Feb; 40(2):180-191. PubMed ID: 29769744
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Neuroprotective effects of acetyl-l-carnitine (ALC) in a chronic MPTP-induced Parkinson's disease mouse model: Endothelial and microglial effects.
    Burks S; Raymick J; Robinson B; Hanig J; Sarkar S
    Neurosci Lett; 2019 Jun; 703():86-95. PubMed ID: 30890473
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.